CF
CELG

Copperwynd Financial’s Celgene Corp CELG Stock Holding History

Copperwynd Financial’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,813
Closed -$445K – 115
2019
Q2 		$445K Buy
4,813
+81
+2% +$7.69K 0.26% 67
2019
Q1 		$446K Buy
4,732
+215
+5% +$18.8K 0.27% 64
2018
Q4 		$289K Sell
4,517
-77
-2% -$5.68K 0.18% 79
2018
Q3 		$411K Buy
4,594
+361
+9% +$31.9K 0.25% 68
2018
Q2 		$336K Buy
4,233
+1,070
+34% +$88.8K 0.24% 71
2018
Q1 		$282K Buy
3,163
+442
+16% +$42.4K 0.19% 80
2017
Q4 		$284K Buy
+2,721
New +$307K 0.21% 78

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Copperwynd Financial's CELG Position: Q3 2019 in Review

Copperwynd Financial sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 4,813 shares — an estimated $445K sold.

Copperwynd Financial first reported a position in CELG in Q4 2017 and held it in 7 quarters. The position peaked at $446K in Q1 2019. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Copperwynd Financial reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Copperwynd Financial sold 4,813 Celgene Corp shares in Q3 2019, an estimated $445K.
  • Copperwynd Financial first reported a position in Celgene Corp in Q4 2017 and held it in 7 quarters.
  • Copperwynd Financial's Celgene Corp position peaked at $446K in Q1 2019.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Copperwynd Financial's 13F filing for Q3 2019, filed 12 Nov 2019.